International Journal of Clinical Medicine

Vol.3 No.4(2012), Paper ID 20886, 7 pages

DOI:10.4236/ijcm.2012.34052

 

Survival Outcome in Metastatic Colorectal Cancer Patients Treated with Bevacizumab Followed by Cetuximab

 

Kozo Kataoka, Akiyoshi Kanazawa, Akio Nakajima, Hisahiro Hosogi, Seiichiiro Kanaya, Takeshi Nagasaka, Yukihiro Kono

 

Department of Surgery, Osaka Red-Cross Hospital, Japan
Department of Surgery, Osaka Red-Cross Hospital, Japan
Department of Surgery, Osaka Red-Cross Hospital, Japan
Department of Surgery, Osaka Red-Cross Hospital, Japan
Department of Surgery, Osaka Red-Cross Hospital, Japan
Department of Gastroenterological Surgery and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan
Department of Surgery, Osaka Red-Cross Hospital, Japan

 

Copyright © 2012 Kozo Kataoka, Akiyoshi Kanazawa, Akio Nakajima, Hisahiro Hosogi, Seiichiiro Kanaya, Takeshi Nagasaka, Yukihiro Kono et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


K. Kataoka, A. Kanazawa, A. Nakajima, H. Hosogi, S. Kanaya, T. Nagasaka and Y. Kono, "Survival Outcome in Metastatic Colorectal Cancer Patients Treated with Bevacizumab Followed by Cetuximab," International Journal of Clinical Medicine, Vol. 3 No. 4, 2012, pp. 263-269. doi: 10.4236/ijcm.2012.34052.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.